Clear Creek Financial Management LLC Buys Shares of 1,728 The Clorox Company $CLX

Clear Creek Financial Management LLC bought a new stake in The Clorox Company (NYSE:CLX) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,728 shares of the company’s stock, valued at approximately $207,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. grew its position in Clorox by 0.4% in the first quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company’s stock valued at $2,293,135,000 after acquiring an additional 65,924 shares during the last quarter. Northern Trust Corp grew its position in Clorox by 2.3% in the first quarter. Northern Trust Corp now owns 1,528,920 shares of the company’s stock valued at $225,133,000 after acquiring an additional 34,655 shares during the last quarter. Invesco Ltd. grew its position in Clorox by 7.4% in the first quarter. Invesco Ltd. now owns 1,361,710 shares of the company’s stock valued at $200,512,000 after acquiring an additional 94,371 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Clorox by 3.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company’s stock valued at $170,406,000 after acquiring an additional 41,485 shares during the last quarter. Finally, Hsbc Holdings PLC grew its position in Clorox by 118.8% in the first quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock valued at $159,699,000 after acquiring an additional 589,544 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of recent research reports. UBS Group cut their price target on Clorox from $134.00 to $128.00 and set a “neutral” rating on the stock in a research note on Wednesday. Citigroup cut their price target on Clorox from $135.00 to $130.00 and set a “neutral” rating on the stock in a research note on Wednesday. Morgan Stanley cut their price target on Clorox from $150.00 to $137.00 and set an “equal weight” rating on the stock in a research note on Friday, August 1st. Bank of America cut their price target on Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research note on Wednesday. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Clorox in a research note on Saturday, September 27th. One research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, Clorox has a consensus rating of “Reduce” and a consensus target price of $131.92.

Clorox Price Performance

Clorox stock opened at $120.14 on Friday. The stock’s 50 day moving average is $122.21 and its 200 day moving average is $128.69. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The firm has a market cap of $14.63 billion, a P/E ratio of 18.43, a P/E/G ratio of 0.98 and a beta of 0.52. The Clorox Company has a one year low of $116.53 and a one year high of $171.37.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm’s quarterly revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, research analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be paid a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.1%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox’s payout ratio is currently 76.07%.

Insiders Place Their Bets

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.57% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.